Bioheng Therapeutics
PrivateLast Round
Series B
Mar 24, 2021
Total Funding Raised
$97.97M
Company Overview
Bioheng Therapeutics is a biopharmaceutical company that develops allogeneic, off-the-shelf universal CAR-T cell therapies for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioheng Therapeutics Comparables
Compare Bioheng Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allotera Therapeutics | 89% | |
| AvenCell | 82% | |
| Century Therapeutics | 78% | |
Bioheng Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 24, 2021 | ||||
| Series A | Feb 14, 2019 | ||||
| Angel | Apr 1, 2018 |
Key People
Founding team and executive leadership
Bioheng Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Series B |
| Hillhouse Investment | Series B |
| Lanchi Ventures | Series B |
| GL Ventures | Series B |
| Octagon Capital Advisors | Series B |
| BlueRun Ventures | Series B |
| Octagon Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2025
Presented latest clinical data for CAR-T product CTD402 at an event.
Bioheng Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioheng Therapeutics's valuation, stock price, and market status.